Skip to content

Headphone DD-45 100306-US

by PATH medical GmbH

Ref 100306-US

Headphone DD-45 100306-US is a device classified as Class IIa in the EU and Class II in the US made by PATH medical GmbH, registered in EUDAMED on 28 May 2026 (Basic UDI-DI 0426022Headphones-2a7R), cleared under FDA 510(k) K133012 on 9 Jun 2014 and listed in FDA GUDID since 31 Aug 2016 (UDI-DI 04260223141652), active as of 25 Oct 2026. 4 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K133012

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number0426022Headphones-2a7R Basic UDI-DI 04260223141652UDI-DIDate28 May 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number04260223141652 UDI-DI Date31 Aug 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK133012 Date9 Jun 2014DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 0426022Headphones-2a7R registered 28 May 2026 Active
  • FDA 510(k) K133012 decided 9 Jun 2014 Active
  • FDA GUDID UDI-DI 04260223141652 listed 31 Aug 2016 Listed

Recalls

4 recalls · 4 ongoing · FDA

  • 4 recalls, same reason

    • Ongoing Z-0403-2024 FDA Class II initiated 26 Sep 2023
    • Ongoing Z-0401-2024 FDA Class II initiated 26 Sep 2023
    • Ongoing Z-0404-2024 FDA Class II initiated 26 Sep 2023
    • Ongoing Z-0402-2024 FDA Class II initiated 26 Sep 2023

    Affected lots of product may experience technical distortions to a greater extent than expected.

Timeline

7 dated events

  1. Cleared FDA 510(k) K133012
  2. Listed FDA GUDID 04260223141652
  3. Recall initiated FDA recalls Z-0403-2024
  4. Recall initiated FDA recalls Z-0401-2024
  5. Recall initiated FDA recalls Z-0404-2024
  6. Recall initiated FDA recalls Z-0402-2024
  7. Registered EUDAMED 0426022Headphones-2a7R

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Hp-06 EUDAMED
Headphone DD-45 GUDID
Generic name
Evoked-potential audiometer
Device name
Headphone
Model / reference
100306-US
Primary DI / UDI-DI
04260223141652
Basic UDI-DI
0426022Headphones-2a7R
510(k) Number
FDA product code
GWJ, EWO
EMDN code
Z12140380, Z12140480, Z12149080
GMDN term
Evoked-potential audiometer
Device class
Class IIa EUDAMED
Class II GUDID
Regulation number
882.1900, 874.1050
EU registration type
Standard device
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IIa
GUDID
Class II

Device class is stated on each registry's own scale: Class IIa in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Related devices

Category: Evoked-potential audiometer

Cleared under the same submission (K133012)

and 8 more cleared under K133012

Similar devices in this category

Other devices filed under EVOKED POTENTIAL AUDIOMETRY INSTRUMENTS.

Other devices from PATH medical GmbH

See all devices from PATH medical GmbH →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (22, all answered No)